6 Trends PhDs Must Know About The Biopharma Market

I had been working in the same lab for a few years.

Doing the same experiments with the same techniques, not really learning anything new.

I felt like I was going nowhere and not developing any useful skills.

I wanted to leave academia, but what good were my abilities outside of the academic environment?

It seemed like everyone around me just wanted to stay in academia.

I felt stuck in my dead-end academic job until I received a call from an old friend.

She was working in the biotech industry and had moved through a few companies.

To my surprise, she had found many opportunities available to her as a PhD outside of academia.

She explained all the exciting work that was currently being done in biopharma.

I suddenly realized there was a whole other world beyond academia.

I had been living in a miserable academic bubble and was finally seeing what was really available outside the university.

But, I had no idea where to start my job search.

It all seemed so overwhelming.

By networking with my friend, I was able to set up a few informational interviews and learn about the variety of positions in biopharma.

With a lot of research and a little coaching from my friend, I am confidently pursuing a new career in industry.

Why There Are Big Opportunities For PhDs In The Biopharma Market

Biotechnology and pharma have been growing steadily for many years now, and there is no sign that this growth will plateau any time soon.

As reported by Ernst and Young, despite a decrease in biopharma market capitalization last year, the industry still saw a 14% increase in the number of employees.

And this year, the industry has bounced back and is looking strong.

The emergence of strong Chinese venture capitalism and the $30 billion Johnson & Johnson’s acquisition of Swiss bellwether Actelion have set the year off on the right foot.

Additionally, the boom in both medicine and biotechnology has seen some tech industry veterans getting their feet wet in the biopharma industry.

As reported in The New York Times, Larry Page, co-founder of Google, started the company Calico to invest in the study of aging and the diseases that come with it.

For PhDs making the transition from academia to industry, this means traditional biotech and pharmaceuticals companies should not be the only places you are looking at for employment.

There are many new and growing companies looking to hire talented PhDs.

According to the US Department Of Commerce, in a single year, the biopharma industry added $1.2 trillion dollars to the US economic output.

There is no shortage of opportunity for PhDs in the biopharma industry.

But, to beat out the competition and land the industry position you want, you MUST be aware of current industry trends.

Companies are often weary of hiring academic PhDs because they lack the business acumen required to succeed in industry.

Prove that you are a PhD who is ready to become an industry professional by following and understanding the latest industry trends.

6 Current Trends In The Biopharma Market That PhDs Must Know

The world of science and technology moves fast.

It can be difficult to keep track of everything.

However, it is essential that you put in the effort and learn about what is happening in industry.

This information affects you, your job search, and your future job prospects.

Here are 7 current trends in biopharma that PhDs must be aware of…

1. CRISPR/Gene editing.

With the advent of CRISPR, the world of gene editing has changed dramatically.

The CRISPR method holds great potential for use in many applications.

The method itself is known to be inexpensive, compared to older methods, giving it the economical edge for widespread use.

Recently, as reported by Nature, CRISPR has successfully been used to edit the genome in human embryos and fix disease-causing mutations.

CRISPR is also making its way into the antibiotic market.

Fiercebiotech reported that Eligo Bioscience recently acquired $20 million from Khosla Ventures and Seventure to look into research using CRISPR to fight antibiotic-resistant bacteria.

With seemingly unlimited uses for CRISPR in healthcare, there has been an unsurprising rise in CRISPR-related funding and patent applications.

CRISPR is considered to be the discovery of the 21st century, and as more applications are investigated, CRISPR will surely continue to grow.

PhDs with technical experience in CRISPR gene editing should be aware of the many applications of this technology in industry.

By leveraging both your technical and transferable skills, being familiar with the CRISPR method opens a variety of doors in industry.

2. Precision medicine.

The Precision Medicine Initiative, originally formed to create a more personalized cancer treatment method, is now moving toward developing personalized treatment for all diseases.

The one-size-fits-all model for treatment of human diseases is coming to an end.

With this shift in treatment model, there is a need for new developments in diagnostics, treatments, and data management.

In terms of data solutions, there is a push to combine genomic information with clinical and lifestyle data to fill any voids in precision medicine. Notably, companies like IBM, Watson, N-Of-One, and 2bPrecise LLC have entered this field.

There was also a recent analysis done by the Diaceutics Group, where they found that two-thirds of phase 3 pipeline therapies, dependent on diagnostics and biomarkers, were in non-oncology fields.

Last but not least, Illumina and Vertex have been investing their capital into precision medicine, and both stocks have risen significantly.

3. Immuno-Oncology, CAR T cells.

This is a new field where a patient’s own immune cells are modified to fight against cancer when reintroduced into the patient’s body.

The cells are given a foreign antigen from a dead virus, called the chimeric antigen receptor (CAR), which allows the cells to recognize tumor cells.

Although a part of precision medicine, attention on CAR T cells has recently overshadowed many other forms of precision therapy and thus, it has been separated into its own category.

Clinical trials have been restricted to patients with advanced stages of cancer, but recently the FDA approved a CAR T cell therapy by Novartis for acute lymphoblastic leukemia in children, marking the first FDA approval in the CART T cell field.

Due to the high success rate of this new therapy, stocks in CART T cell therapy companies such as iShares Nasdaq Biotechnology ETF (IBB), BlubirdBio, Juno Therapeutics, and Nektar Therapeutics have risen substantially, as reported by CNBC.

4. Microbiome.

Research into the importance of the microbiome on overall health is a current hot topic.

Studies have linked the microbiome to several human ailments, including obesity, gastrointestinal disorders, and even diseases that affect the brain and behavior.

So, it is no surprise that there has been a high interest in companies researching the microbiome.

In fact, as reported by The Wall Street Journal, the growth of venture-capital investment in companies focusing on microbiome solutions has outpaced the growth of overall venture-capital investment.

Last year alone, there was $616.9 million raised for microbiome companies — this is more than the previous 4 years combined.

Although the highly publicised microbiome news has mainly focused on companies interested in the biomedical uses of the microbiome, such as Human Longevity Inc., other companies are investigating alternative uses for the microbiome.

For example, Indigo Agriculture Inc., has found that microbiome bacteria can be used to make the cotton plant more drought-resistant.

The applications of microbiome research are diverse, just like many of the other trends in biopharma, so as a PhD you need to remember to keep an open mind when looking for industry positions.

5. Antibiotics discovery.

No major antibiotic discoveries have been made since the1960s.

Infectious bacteria are gaining resistance to our current antibiotics, which causes alarm worldwide.

Cases have arisen where none of our current antibiotics are able to fight an infection, and the patient has died.

Antibiotic resistance is not only passed down from drugs, but from our food sources as well.

Recently, fish farms from around the world were able to find and measure antibiotics in their fishmeal, which ultimately led to resistance genes being found in oceanic bacteria.


As reported by Forbes, many big pharma corporations seem to have given up on finding new antibiotics, due to the lack of profitability in these drugs.

However, government funding into antibiotic development has increased.

France recently invested €15 million into companies trying to discover the next generation of antibiotics, such as Destiny Pharma and Summit Therapeutics.

Several European countries and South Africa have come together to invest €56.5 million in the Global Antibiotic Research and Development Partnership (GARDP).

And, CARB-X is the result of a transatlantic partnership and was given $350 million to combat drug resistance.

With so much concern and funds being shuttled into antibiotics discovery, this field is in the spotlight for venture capitalists investing into startup companies willing to take on the risk of developing new antibiotics.

The antibiotic discovery field highlights that concern industry include for-profit companies, non-profit companies, and government institutions — all of which have positions that need talented PhDs.

6. R&D outsourcing.

We live in a society that demands economical growth, and with greater pressure on biopharma to churn out the next generation of treatments while still making a profit, companies are increasingly outsourcing their R&D work.

Companies are feeling the pressure of R&D costs, as there was a 12% increase in R&D spending last year.

Biopharma companies are looking for ways to reduce this cost, including outsourcing

It is more cost-effective to send your R&D work to an established laboratory than to build the infrastructure and hire the people needed to finish the job using your own capital.

This trend is responsible for the rise of the Contract Research Organization (CRO).

The R&D outsourcing market is also expanding the use of e-commerce.

It is estimated that 70-80% of sales and marketing of life science tools will be done using e-commerce by 2020.

Currently, 8 of 10 pharmaceutical companies have used Science Exchange, the world’s leading online marketplace for such services, to purchase external research services.

No matter where you are in your career, it is always good to keep in touch with the latest industry trends. Not only could knowing these trends lead you to your next job, but it will give you insight on how business transactions are made, which is also important to know in industry. A few trends to be aware of now are the widespread use of CRISPR gene editing, the rise of precision medicine, the development of CAR T cells, the increasing interest in microbiome and medical cannabis research, and the current R&D outsourcing trend. It is time to get out of the lab and start looking for an industry career. It is never too early or too late to start looking at what options lay beyond the horizon.

To learn more about 6 Trends PhDs Must Know About The Biopharma Market, including instant access to our exclusive training videos, case studies, industry insider documents, transition plan, and private online network, get on the wait list for the Cheeky Scientist Association.

Join Cheeky Scientist Association
Get Free Job Search Content Weekly
Tavis Mendez, PhD
Tavis Mendez, PhD

Tavis Mendez is a scientist in transition who has a passion for benchwork and communicating biomedical research to the public. Dreaming of becoming a scientist since his adolescent years, he obtained his Ph.D. in a parasitology lab, but has also travelled across the USA and to Asia to study cancer and hypertension. In his free time, Tavis loves to conduct culinary experiments in his kitchen.

Similar Articles

5 Ways Academic Career Centers Fail PhDs

5 Ways Academic Career Centers Fail PhDs

By: Amanda Johnson

If anyone should have known how to execute a PhD job search, it was me. The institution I was earning my PhD at was one of the top 10 across the nation. It was awarded a National Institutes of Health (NIH) Broadening Experiences in Scientific Training (BEST) in the award’s first funding cycle. My career center was one of the best. What made it one of the top ranking career centers was that they provided opportunities and resources to help trainees prepare for a diverse range of careers. I had taken courses on intellectual property, college teaching, and participated in training…

A PhD In Leadership: 9 Academic Skills That Turn You Into A Boss

A PhD In Leadership: 9 Academic Skills That Turn You Into A Boss

By: Isaiah Hankel, PhD

How many PhDs miss their calling as being a leader and or a boss because of academic failure and not realizing the leadership skills they have?  I remember my own academic education well. Like other PhDs, no one taught me how to develop my leadership skills. Leadership is a core part of real life, of industry. But it’s not a focal point for academia, which is why so many students get their PhDs only to face a harsh reality… Instead of success and recognition, PhDs feel used. They’ve been used by a university system that chewed them up and spit…

7 Ways To Keep Your Job Search Alive In A Recession

7 Ways To Keep Your Job Search Alive In A Recession

By: Isaiah Hankel, PhD

I’ve lost a job. I was offered a contract, and they pulled it back. Everybody is ignoring me on LinkedIn now.  I was communicating with somebody about an upcoming interview, and now they’re not replying to my emails. My postdoc is not going to be renewed.  This is the kind of message I’ve been getting from countless PhDs all over the world. The recession has made things challenging for everyone. A lot of PhDs thought academia was going to take care of them, but they’ve found out the hard way that it isn’t true. For weeks now, I’ve been warning…

How These 3 Leadership Skills Can Protect Your Career During A Recession

How These 3 Leadership Skills Can Protect Your Career During A Recession

By: Sarah Smith, PhD

The current crisis reminds me of something that happened to me years ago, before I had leadership skills. I had an interview with a big company, and it was scheduled to take place on an upper floor of a tall building. I took the elevator, which turned out to be the wrong choice. Normally, I’d have chosen the stairs, but I was feeling nervous and didn’t want to make my heart rate increase – it was already beating fast. The elevator got about halfway up to my floor and abruptly stopped. The doors didn’t open. There were several other people…

5 Ways To Limit PhD Anxiety And Protect Your Career

5 Ways To Limit PhD Anxiety And Protect Your Career

By: Elliott Brecht, PhD

You should have seen my academic CV. I would have set off anyone’s anxiety. It was a total disaster. By academia’s standards, it was fine. But I had a real monster of a CV, over 5 pages long and full of academic jargon. And there was no cover letter either. Can you guess what industry employers did after taking a glimpse at my CV? They probably threw it away – that’s assuming it even reached employers. More likely, it was filtered out of candidacy by application tracking software. You might think that, given the current situation, you should be focusing…

Secure PhD Jobs With The 15-Point Coronavirus Career Plan

Secure PhD Jobs With The 15-Point Coronavirus Career Plan

By: Isaiah Hankel, PhD

Isaiah Hankel has your career guide to navigating the world of PhD jobs during the coronavirus crisis and using this temporary downtime to your advantage. The financial markets have crashed worldwide.  I can tell you from experience what’s going to happen next. I was a PhD student in 2008 during the financial crisis, and history tells us the hiring market is next to crash. After 2008, I felt like there were no jobs, and I had no industry network to connect with. My PI couldn’t help me – he didn’t know anybody either.  He was in the academic bubble with…

5 Visa Processes International PhDs Master To Lock Down A Job

5 Visa Processes International PhDs Master To Lock Down A Job

By: Arunodoy Sur, PhD

Visa Processes for PhDs can be complicated – luckily, contributing author Arunundoy Sur, PhD, can break it down for you. I started applying for jobs early. I was preparing to graduate, and I felt lucky to receive some positive responses right away. In a very short period of time, I had interviews lined up with 4 different companies. I went through multiple rounds of interviews and even reached the stage of salary negotiation in 3 of these cases. It all seemed to be going well. Being proactive was paying off, and now I had a new job lined up before…

Coronavirus Panic Proves The World Needs PhDs In These 9 Industry Roles

Coronavirus Panic Proves The World Needs PhDs In These 9 Industry Roles

By: Isaiah Hankel, PhD

Isaiah Hankel, PhD, discusses the global reaction to the coronavirus and how it demonstrates that industry needs PhDs more than ever. The need for scientists is rising, and it’s rising fast. With the recent outbreak of the “coronavirus,” media have reported all kinds of information, not all of it true and accurate. News and other media outlets thrive on timely reportage, and unfortunately, panicked viewers will pay more attention than relaxed ones. The effects of this panic are already observable. Who is in the best possible position to work against this alarmist racket?  Scientists holed up in academia? No. In…

3 Strategies For Motivation And Accountability During A Job Search

3 Strategies For Motivation And Accountability During A Job Search

By: Sarah Smith, PhD

As with most long-term projects, consistent accountability requires motivation. Research done at the University of Rochester identified two types of motivation: intrinsic and extrinsic. Intrinsic motivation is the kind of curiosity that drives you to pursue knowledge all the way to mastery. PhDs almost always have a lot of this motivation. Loving your field of study and wanting to advance it is what made you push your way through a doctoral program. Intrinsic motivation derives from natural satisfaction – when the task is its own reward. The problem is that intrinsic motivation rarely drives a job search. What PhDs need…

Top Industry Career eBooks

Complete LinkedIn Guide For PhDs

Complete LinkedIn Guide For PhDs

Isaiah Hankel

The LinkedIn tips & strategies within have helped PhDs from every background get hired into top industry careers.

20 Most Popular Industry Career Tracks For PhDs

20 Most Popular Industry Career Tracks For PhDs

Isaiah Hankel, PhD & Arunodoy Sur, PhD

Learn about the top 20 industry careers for PhDs (regardless of your academic background). In this eBook, you will gain insight into the most popular, highest-paying jobs for PhDs – all of which will allow you to do meaningful work AND get paid well for it.

Industry Resume Guide for PhDs

Industry Resume Guide for PhDs

Isaiah Hankel, PhD

Learn how to craft the perfect industry resume to attract employers. In this eBook for PhDs, you will get access to proven resume templates, learn how to structure your bullet points, and discover which keywords industry employers want to see most on PhD resumes.